<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Changes in DNA methylation, whether hypo- or hypermethylation, have been shown to be associated with the progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Methylation changes substantially in the progression from <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa to <z:mpath ids='MPATH_270'>adenoma</z:mpath> and to <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>This phenomenon has not been studied extensively and studies have been restricted to individual CpG islands, rather than taking a whole-genome approach </plain></SENT>
<SENT sid="3" pm="."><plain>We aimed to study genome-wide methylation changes in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We obtained 10 fresh-frozen <z:mpath ids='MPATH_458'>normal</z:mpath> tissue-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> sample pairs, and five fresh-frozen <z:mpath ids='MPATH_270'>adenoma</z:mpath> samples </plain></SENT>
<SENT sid="5" pm="."><plain>These were run on the lllumina HumanMethylation27 whole-genome methylation analysis system </plain></SENT>
<SENT sid="6" pm="."><plain>Differential methylation between <z:mpath ids='MPATH_458'>normal</z:mpath> tissue, <z:mpath ids='MPATH_270'>adenoma</z:mpath> and <z:mp ids='MP_0002038'>carcinoma</z:mp> was analysed using Bayesian regression modelling, gene set enrichment analysis (GSEA) and hierarchical clustering (HC) </plain></SENT>
<SENT sid="7" pm="."><plain>The highest-rated individual gene for differential methylation in <z:mp ids='MP_0002038'>carcinomas</z:mp> versus <z:mpath ids='MPATH_458'>normal</z:mpath> tissue and <z:mpath ids='MPATH_270'>adenomas</z:mpath> versus <z:mpath ids='MPATH_458'>normal</z:mpath> tissue was GRASP (padjusted  = 1.59 × 10(-5) , BF = 12.62, padjusted  = 1.68 × 10(-6) , BF = 14.53) </plain></SENT>
<SENT sid="8" pm="."><plain>The highest-rated gene when comparing <z:mp ids='MP_0002038'>carcinomas</z:mp> versus <z:mpath ids='MPATH_270'>adenomas</z:mpath> was ATM (padjusted  = 2.0 × 10(-4) , BF = 10.17) </plain></SENT>
<SENT sid="9" pm="."><plain>Hierarchical clustering demonstrated poor clustering by the CIMP criteria for methylation </plain></SENT>
<SENT sid="10" pm="."><plain>GSEA demonstrated methylation changes in the Netrin-<z:chebi fb="8" ids="53090">DCC</z:chebi> and SLIT-ROBO pathways </plain></SENT>
<SENT sid="11" pm="."><plain>Widespread changes in DNA methylation are seen in the transition from <z:mpath ids='MPATH_270'>adenoma</z:mpath> to <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>The finding that GRASP, which encodes the general receptor for <z:chebi fb="0" ids="16749">phosphoinositide</z:chebi> 1-associated scaffold protein, was differentially methylated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is interesting </plain></SENT>
<SENT sid="13" pm="."><plain>This may be a potential biomarker for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>Copyright © 2012 Pathological Society of Great Britain and Ireland </plain></SENT>
<SENT sid="15" pm="."><plain>Published by John Wiley &amp; Sons, Ltd </plain></SENT>
</text></document>